Clinical Trial Update: Effects of Oral Glucosamine on Insulin and Blood Vessel Activity in Normal and Obese People [Phase 1]

View source ↗

Summary

A Phase 1 trial update assessing whether oral glucosamine affects insulin responses and blood vessel activity in normal and obese individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Drugs mentioned

• Glucosamine (glucosamine)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Obesity, Insulin Resistance | Phase 1 | Status: COMPLETED